Oncolytics Biotech Inc (ONC) - Financial and Strategic SWOT Analysis Review

Oncolytics Biotech Inc (ONC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oncolytics Biotech Inc (Oncolytics Biotech) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The companys lead product candidate, pelareorep, is an unmodified reovirus that is an intraosseous (I-O) viral agent indicated for systemic administration for the treatment of hematological malignancies and solid tumors. Pelareoreps anti-tumor activity facilitates selective replication of virus and lysis of tumor cells; activation of innate immunity and cascade of chemokines/cytokines causing activation of natural killer (NK) cells to attack cancer cells; and specific adaptive immune response triggered by viral- and tumor-associated antigens. The company works in collaboration with various pharmaceutical companies to advance its clinical trials for the treatment of cancer. Oncolytics Biotech is headquartered in Calgary, Alberta, Canada.

Oncolytics Biotech Inc Key Recent Developments

May 08,2020: Oncolytics Biotech reports 2020 first quarter financial results and operational highlights
Apr 30,2020: Oncolytics Biotech announces changes to annual general meeting
Mar 05,2020: Oncolytics Biotech reports fourth quarter and full year 2019 financial results and operational highlights
Jan 16,2020: New study indicates helper cells may kill cancerous tumors
Nov 12,2019: Oncolytics Biotech reports 2019 third quarter financial results and operational highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company
Oncolytics Biotech Inc - Key Facts
Oncolytics Biotech Inc - Key Employees
Oncolytics Biotech Inc - Key Employee Biographies
Oncolytics Biotech Inc - Major Products and Services
Oncolytics Biotech Inc - History
Oncolytics Biotech Inc - Company Statement
Oncolytics Biotech Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Oncolytics Biotech Inc - Business Description
R&D Overview
Oncolytics Biotech Inc - Corporate Strategy
Oncolytics Biotech Inc - SWOT Analysis
SWOT Analysis - Overview
Oncolytics Biotech Inc - Strengths
Oncolytics Biotech Inc - Weaknesses
Oncolytics Biotech Inc - Opportunities
Oncolytics Biotech Inc - Threats
Oncolytics Biotech Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Oncolytics Biotech Inc, Recent Deals Summary
Section 5 Companys Recent Developments
May 08, 2020: Oncolytics Biotech reports 2020 first quarter financial results and operational highlights
Apr 30, 2020: Oncolytics Biotech announces changes to annual general meeting
Mar 05, 2020: Oncolytics Biotech reports fourth quarter and full year 2019 financial results and operational highlights
Jan 16, 2020: New study indicates helper cells may kill cancerous tumors
Nov 12, 2019: Oncolytics Biotech reports 2019 third quarter financial results and operational highlights
Oct 17, 2019: Oncolytics Biotech appoints experienced financial and strategic leader Leonard Kruimer to board of directors
Aug 13, 2019: Oncolytics Biotech reports 2019 second quarter financial results and operational highlights
May 03, 2019: Oncolytics Biotech reports 2019 first quarter financial results and operational highlights
Mar 08, 2019: Oncolytics Biotech announces 2018 year-end results and operational highlights
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Oncolytics Biotech Inc, Key Facts
Oncolytics Biotech Inc, Key Employees
Oncolytics Biotech Inc, Key Employee Biographies
Oncolytics Biotech Inc, Major Products and Services
Oncolytics Biotech Inc, History
Oncolytics Biotech Inc, Other Locations
Oncolytics Biotech Inc, Subsidiaries
Oncolytics Biotech Inc, Key Competitors
Oncolytics Biotech Inc, Ratios based on current share price
Oncolytics Biotech Inc, Annual Ratios
Oncolytics Biotech Inc, Annual Ratios (Cont...1)
Oncolytics Biotech Inc, Interim Ratios
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Oncolytics Biotech Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Oncolytics Biotech Inc, Performance Chart (2015 - 2019)
Oncolytics Biotech Inc, Ratio Charts
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Oncolytics Biotech Inc (ONC) - Financial and Strategic SWOT Analysis Review

Oncolytics Biotech Inc (ONC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Edesa Biotech Inc (EDSA) - Financial and Strategic SWOT Analysis Review

Edesa Biotech Inc (Edesa Biotech) is a clinical-stage biopharmaceutical company, which focuses on the development of gastrointestinal and dermatological diseases, including alternatives to topical steroids. The companys clinical product pipeline

USD 300 View Report

Kane Biotech Inc Strategic Analysis Review- Kane Biotech Inc SWOT, Outlook, Operations and Financial Profile

Kane Biotech Inc Company Profile provides strategic analysis of Kane Biotech Inc Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available